The Society for Immunotherapy of Cancer (SITC) hosted the “Primer on Tumor Immunology and Caner Immunotherapy™” during the 37th Annual Meeting & Pre-Conference Programs on November 9, 2022. Available here are the presentation slides and video from “Session IV: Biomarkers of Response to Immunotherapies,” as permitted by presenters.
The target audience for this annual, one-day educational program includes students, postdoctoral fellows and technicians from academia and industry, as well as physicians and scientists at more senior levels who wish to solidify their understanding of tumor immunology and immunotherapy, pharmacists and registered nurses.
The understanding of cancer immunobiology has increased dramatically in recent years, leading to the successful development of novel immune-based treatment options to improve cancer patient outcomes. The SITC Primer on Tumor Immunology and Cancer Immunotherapy™ is designed to provide a foundation for understanding core immunology principles as they relate to basic and clinical research in immunotherapy of cancer. The Primer on Tumor Immunology and Cancer Immunotherapy™ will also touch on emerging therapies and technologies to ensure attendees at all levels stay updated in our expanding field, while also laying a comprehensive foundational base for all SITC attendees.
To view the entire program schedule (including presenter permission to post) please click here.
Program: Primer on Tumor Immunology and Cancer Immunotherapy™; Date: November 9, 202201:42:07